ArticleOxford medical case reports2025
Bilateral adrenal infarction in a patient with essential thrombocythemia: a case report and brief literature review.
Article in Oxford medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adrenal infarction (AI) is rare condition caused by inadequate blood supply to the adrenal glands, with few reports of its association with essential thrombocythemia (ET). Here, we report a case of bilateral AI as an initial thrombotic complication in a patient with ET. A 69-year-old man presented with right abdominal pain. Abdominal computed tomography (CT) showed diffuse enlargement and poor enhancement of bilateral adrenal glands. He was diagnosed with bilateral AI. Based on positive screening for thrombocytosis and the Janus kinase 2 V617F mutation, he was diagnosed with ET. After low-dose aspirin therapy, he showed no symptom recurrence. The cortisol response in the adrenocorticotropic hormone stimulation test decreased at onset but improved after three months. Furthermore, abdominal CT revealed improvement in bilateral adrenal enlargement and enhancement. In patients presenting with AI, ET should be considered as a potential underlying disease, and early diagnosis and treatment is important to prevent recurrence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.